Gynecology Collaboration, R&D, and Licensing Deals Trends globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
DelveInsight s, Cryptococcosis Pipeline Insight 2023 report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Cryptococcosis pipeline landscape. It covers the.
/PRNewswire/ Mycovia Pharmaceuticals, Inc. ("Mycovia"), an emerging biopharmaceutical company, today announced that Jiangsu Hengrui Pharmaceuticals Co., Ltd.
The global Vulvovaginal Candidiasis Treatment Market is currently valued at US$ 1035 Million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare sector the market is likely to propel to US$1607 Million by 2033.VVC prevalence has increased due to growing diabetes.
The global Vulvovaginal Candidiasis Treatment Market is currently valued at US$ 1035 Million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare sector the market is likely to propel to US$1607 Million by 2033.VVC prevalence has increased due to growing diabetes.